This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.

  82R562 JSC-D
 
  By: Shapiro, et al. S.B. No. 331
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to adding certain synthetic cannabinoids to Penalty Group
  2 of the Texas Controlled Substances Act.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 481.103(a), Health and Safety Code, is
  amended to read as follows:
         (a)  Penalty Group 2 consists of:
               (1)  any quantity of the following hallucinogenic
  substances, their salts, isomers, and salts of isomers, unless
  specifically excepted, if the existence of these salts, isomers,
  and salts of isomers is possible within the specific chemical
  designation:
                     alpha-ethyltryptamine;
                     alpha-methyltryptamine;
                     4-bromo-2, 5-dimethoxyamphetamine (some trade or
  other names:  4-bromo-2, 5-dimethoxy-alpha-methylphenethylamine;
  4-bromo-2, 5-DMA);
                     4-bromo-2, 5-dimethoxyphenethylamine;
                     Bufotenine (some trade and other names:  3-(beta-
  Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)- 5-
  indolol; N, N-dimethylserotonin; 5-hydroxy-N, N-
  dimethyltryptamine; mappine);
                     Diethyltryptamine (some trade and other
  names:  N, N-Diethyltryptamine, DET);
                     2, 5-dimethoxyamphetamine (some trade or other
  names:  2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA);
                     2, 5-dimethoxy-4-ethylamphetamine (trade or other
  name:  DOET);
                     2, 5-dimethoxy-4-(n)-propylthiophenethylamine
  (trade or other name:  2C-T-7);
                     Dimethyltryptamine (trade or other name:  DMT);
                     Dronabinol (synthetic) in sesame oil and
  encapsulated in a soft gelatin capsule in a U.S. Food and Drug
  Administration approved drug product (some trade or other names for
  Dronabinol:  (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9-
  trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9-
  (trans)- tetrahydrocannabinol);
                     Ethylamine Analog of Phencyclidine (some trade or
  other names:  N-ethyl-1-phenylcyclohexylamine, (1-
  phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine,
  cyclohexamine, PCE);
                     Ibogaine (some trade or other names:  7-Ethyl-6,
  6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-
  pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.);
                     Mescaline;
                     5-methoxy-N, N-diisopropyltryptamine;
                     5-methoxy-3, 4-methylenedioxy amphetamine;
                     4-methoxyamphetamine (some trade or other
  names:  4-methoxy-alpha-methylphenethylamine;
  paramethoxyamphetamine; PMA);
                     1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP,
  PPMP);
                     4-methyl-2, 5-dimethoxyamphetamine (some trade
  and other names:  4-methyl-2, 5-dimethoxy-alpha-
  methylphenethylamine; "DOM"; "STP");
                     3,4-methylenedioxy methamphetamine (MDMA, MDM);
                     3,4-methylenedioxy amphetamine;
                     3,4-methylenedioxy N-ethylamphetamine (Also
  known as N-ethyl MDA);
                     Nabilone (Another name for nabilone:  (+)-trans-
  3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6,
  6-dimethyl-9H-dibenzo[b,d] pyran-9-one;
                     N-benzylpiperazine (some trade or other
  names:  BZP; 1-benzylpiperazine);
                     N-ethyl-3-piperidyl benzilate;
                     N-hydroxy-3,4-methylenedioxyamphetamine (Also
  known as N-hydroxy MDA);
                     4-methylaminorex;
                     N-methyl-3-piperidyl benzilate;
                     Parahexyl (some trade or other names:  3-Hexyl-1-
  hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d]
  pyran; Synhexyl);
                     1-Phenylcyclohexylamine;
                     1-Piperidinocyclohexanecarbonitrile (PCC);
                     Psilocin;
                     Psilocybin;
                     Pyrrolidine Analog of Phencyclidine (some trade
  or other names:  1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);
                     Tetrahydrocannabinols, other than marihuana, and
  synthetic equivalents of the substances contained in the plant, or
  in the resinous extractives of Cannabis, or synthetic substances,
  derivatives, and their isomers with similar chemical structure and
  pharmacological activity such as:
                           delta-1 cis or trans tetrahydrocannabinol,
  and their optical isomers;
                           delta-6 cis or trans tetrahydrocannabinol,
  and their optical isomers;
                           delta-3, 4 cis or trans
  tetrahydrocannabinol, and its optical isomers;
                           compounds of these structures, regardless of
  numerical designation of atomic positions, since nomenclature of
  these substances is not internationally standardized;
                     Thiophene Analog of Phencyclidine (some trade or
  other names:  1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl
  Analog of Phencyclidine; TPCP, TCP);
                     1-pyrrolidine (some trade or other name:  TCPy);
                     1-(3-trifluoromethylphenyl)piperazine (trade or
  other name:  TFMPP); and
                     3,4,5-trimethoxy amphetamine;
               (2)  Phenylacetone (some trade or other
  names:  Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl
  ketone); [and]
               (3)  unless specifically excepted or unless listed in
  another Penalty Group, a material, compound, mixture, or
  preparation that contains any quantity of the following substances
  having a potential for abuse associated with a depressant or
  stimulant effect on the central nervous system:
                     Aminorex (some trade or other
  names:  aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5-
  phenyl-2-oxazolamine);
                     Amphetamine, its salts, optical isomers, and
  salts of optical isomers;
                     Cathinone (some trade or other names:  2-amino-1-
  phenyl-1-propanone, alpha-aminopropiophenone, 2-
  aminopropiophenone);
                     Etorphine Hydrochloride;
                     Fenethylline and its salts;
                     Lisdexamfetamine, including its salts, isomers,
  and salts of isomers;
                     Mecloqualone and its salts;
                     Methaqualone and its salts;
                     Methcathinone (some trade or other names:  2-
  methylamino-propiophenone; alpha-(methylamino)propriophenone;
  2-(methylamino)-1-phenylpropan-1-one; alpha-N-
  methylaminopropriophenone; monomethylpropion; ephedrone, N-
  methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR
  1431);
                     N-Ethylamphetamine, its salts, optical isomers,
  and salts of optical isomers; and
                     N,N-dimethylamphetamine (some trade or other
  names:  N,N,alpha-trimethylbenzeneethaneamine;
  N,N,alpha-trimethylphenethylamine), its salts, optical isomers,
  and salts of optical isomers; and
               (4)  any quantity of a synthetic chemical compound that
  is a cannabinoid receptor agonist and mimics the pharmacological
  effect of naturally occurring cannabinoids, including:
                     naphthoylindoles structurally derived from
  3-(1-naphthoyl)indole by substitution at the nitrogen atom of the
  indole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
  or 2-(4-morpholinyl)ethyl, whether or not further substituted in
  the indole ring to any extent, whether or not substituted in the
  napthyl ring to any extent, including:
                           JWH-004;
                           JWH-007;
                           JWH-009;
                           JWH-015;
                           JWH-016;
                           JWH-018;
                           JWH-019;
                           JWH-020;
                           JWH-046;
                           JWH-047;
                           JWH-048;
                           JWH-049;
                           JWH-050;
                           JWH-070;
                           JWH-071;
                           JWH-072;
                           JWH-073;
                           JWH-076;
                           JWH-079;
                           JWH-080;
                           JWH-081;
                           JWH-082;
                           JWH-094;
                           JWH-096;
                           JWH-098;
                           JWH-116;
                           JWH-120;
                           JWH-122;
                           JWH-148;
                           JWH-149;
                           JWH-180;
                           JWH-181;
                           JWH-182;
                           JWH-189;
                           JWH-193;
                           JWH-198;
                           JWH-200;
                           JWH-210;
                           JWH-211;
                           JWH-212;
                           JWH-213;
                           JWH-234;
                           JWH-235;
                           JWH-236;
                           JWH-239;
                           JWH-240;
                           JWH-241;
                           JWH-242;
                           JWH-262;
                           JWH-386;
                           JWH-387;
                           JWH-394;
                           JWH-395;
                           JWH-397;
                           JWH-398;
                           JWH-399;
                           JWH-400;
                           JWH-412;
                           JWH-413;
                           JWH-414; and
                           JWH-415;
                     naphthylmethylindones structurally derived from
  1H-indol-3-yl-(1-naphthyl)methane by substitution at the nitrogen
  atom of the indole ring by alkyl, alkenyl, cycloalkylmethyl,
  cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further
  substituted in the indole ring to any extent, whether or not
  substituted in the naphthyl ring to any extent, including:
                           JWH-175;
                           JWH-184;
                           JWH-185;
                           JWH-192;
                           JWH-194;
                           JWH-195;
                           JWH-196;
                           JWH-197; and
                           JWH-199;
                     naphthoylpyrroles structurally derived from
  3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the
  pyrrole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
  or 2-(4-morpholinyl)ethyl, whether or not further substituted in
  the pyrrole ring to any extent, whether or not substituted in the
  naphthyl ring to any extent, including:
                           JWH-030;
                           JWH-145;
                           JWH-146;
                           JWH-147;
                           JWH-150;
                           JWH-156;
                           JWH-243;
                           JWH-244;
                           JWH-245;
                           JWH-246;
                           JWH-292;
                           JWH-293;
                           JWH-307;
                           JWH-308;
                           JWH-346;
                           JWH-348;
                           JWH-363;
                           JWH-364;
                           JWH-365;
                           JWH-367;
                           JWH-368;
                           JWH-369;
                           JWH-370;
                           JWH-371;
                           JWH-373; and
                           JWH-392;
                     naphthylmethylindenes structurally derived from
  1-(1-naphthylmethyl)indene by substitution at the 3-position of
  the indene ring by alkyl, alkenyl, cycloalkylmethyl,
  cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further
  substituted in the indene ring to any extent, whether or not
  substituted in the naphthyl ring to any extent, including JWH-176;
                     phenylacetylindoles structurally derived from
  3-phenylacetylindole by substitution at the nitrogen atom of the
  indole ring with alkyl, alkenyl, cycloalkylmethyl,
  cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further
  substituted in the indole ring to any extent, whether or not
  substituted in the phenyl ring to any extent, including:
                           JWH-167;
                           JWH-201;
                           JWH-202;
                           JWH-203;
                           JWH-204;
                           JWH-205;
                           JWH-206;
                           JWH-207;
                           JWH-208;
                           JWH-209;
                           JWH-237;
                           JWH-248;
                           JWH-249;
                           JWH-250;
                           JWH-251;
                           JWH-252;
                           JWH-253;
                           JWH-302;
                           JWH-303;
                           JWH-304;
                           JWH-305;
                           JWH-306;
                           JWH-311;
                           JWH-312;
                           JWH-313;
                           JWH-314;
                           JWH-315; and
                           JWH-316;
                     cyclohexylphenols structurally derived from
  2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of
  the phenolic ring by alkyl, alkenyl, cycloalkylmethyl,
  cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not
  substituted in the cyclohexyl ring to any extent, including:
                           CP-55,940;
                           CP-47,497; and
                           analogues of CP-47,497, including VII, V,
  VIII, I, II, III, IV, IX, X, XI, XII, XIII, XV, and XVI; and
               cannabinol derivatives, except where contained in
  cannabis or cannabis resin, including tetrahydro derivatives of
  cannabinol and 3-alkyl homologues of cannabinol or of its
  tetrahydro derivatives, such as:
                           delta-9-THC;
                           delta-8-THC;
                           Nabilone;
                           HU-210;
                           HU-211; and
                           WIN-55,212-2.
         SECTION 2.  This Act takes effect September 1, 2011.